SeaCrest Wealth Management LLC decreased its position in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 28.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,424 shares of the company's stock after selling 2,909 shares during the period. SeaCrest Wealth Management LLC's holdings in DocuSign were worth $668,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently modified their holdings of DOCU. State Street Corp grew its position in DocuSign by 2.3% during the third quarter. State Street Corp now owns 5,372,939 shares of the company's stock valued at $333,604,000 after buying an additional 120,743 shares during the period. Pacer Advisors Inc. raised its position in DocuSign by 77.9% in the second quarter. Pacer Advisors Inc. now owns 3,519,969 shares of the company's stock worth $188,318,000 after acquiring an additional 1,541,816 shares during the period. Geode Capital Management LLC grew its position in shares of DocuSign by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 3,483,184 shares of the company's stock valued at $215,789,000 after acquiring an additional 53,554 shares during the period. Clearbridge Investments LLC grew its position in shares of DocuSign by 4.1% during the 2nd quarter. Clearbridge Investments LLC now owns 2,920,842 shares of the company's stock valued at $156,265,000 after acquiring an additional 115,616 shares during the period. Finally, Thrivent Financial for Lutherans increased its stake in shares of DocuSign by 5.2% during the 3rd quarter. Thrivent Financial for Lutherans now owns 2,277,312 shares of the company's stock worth $141,398,000 after purchasing an additional 112,919 shares during the last quarter. Institutional investors own 77.64% of the company's stock.
Wall Street Analyst Weigh In
Several equities analysts recently commented on DOCU shares. Morgan Stanley upped their price objective on DocuSign from $62.00 to $97.00 and gave the company an "equal weight" rating in a research note on Friday, December 6th. Needham & Company LLC reiterated a "hold" rating on shares of DocuSign in a research note on Friday, December 6th. HSBC reissued a "reduce" rating on shares of DocuSign in a report on Friday, December 6th. Robert W. Baird upped their price objective on shares of DocuSign from $59.00 to $100.00 and gave the company a "neutral" rating in a report on Friday, December 6th. Finally, Jefferies Financial Group lifted their target price on shares of DocuSign from $80.00 to $95.00 and gave the stock a "buy" rating in a research note on Tuesday, December 3rd. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, DocuSign presently has an average rating of "Hold" and an average price target of $92.45.
Read Our Latest Report on DocuSign
Insider Activity at DocuSign
In related news, CEO Allan C. Thygesen sold 7,764 shares of the stock in a transaction on Friday, November 1st. The stock was sold at an average price of $69.95, for a total value of $543,091.80. Following the transaction, the chief executive officer now owns 107,825 shares of the company's stock, valued at $7,542,358.75. This represents a 6.72 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Daniel D. Springer sold 581,588 shares of the firm's stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total value of $56,437,299.52. Following the sale, the director now owns 906,430 shares in the company, valued at $87,959,967.20. The trade was a 39.08 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 693,537 shares of company stock valued at $66,575,817. Company insiders own 1.66% of the company's stock.
DocuSign Stock Performance
NASDAQ DOCU traded down $1.56 on Friday, hitting $89.60. The stock had a trading volume of 2,379,616 shares, compared to its average volume of 2,200,811. The firm has a 50-day moving average of $88.26 and a 200-day moving average of $69.77. The company has a market capitalization of $18.10 billion, a price-to-earnings ratio of 18.47, a price-to-earnings-growth ratio of 8.17 and a beta of 0.88. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86.
About DocuSign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.